Invitae Corporation (NVTA) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Invitae Corporation  (NYSE: NVTA)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Invitae's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Invitae's ROI in the third quarter of 2023?
Invitae Corporation had a negative return on investment (ROI) of -113.09%, due to the net loss of $-1 billion, during the twelve months ending in the third quarter of 2023.

Within the Healthcare sector 835 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 4309 to 4681.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM -62.95 % -60.42 % -61.92 % -43.47 % -18.21 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 377 1,371 1,501 1,846 1,913
Return On Investment (TTM) -113.09 % -48.23 % -168.2 % -118.22 % -93.42 %
NVTA's Overall Ranking # 4681 # 4309 # 5092 # 5758 # 5042
Seq. Investment Change TTM -23.17 % -10.53 % -29.48 % -23.57 % -17.92 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1,441 -800 -3,117 -3,106 -3,212

NVTA Company Profile >> Back to NVTA Roi Comparisons >> See Annual NVTA Return On Investment



Return On Investment NVTA's Ranking
Within: No.
Industry # 39
Sector # 836
Overall # 4681

Return On Investment Statistics
High Average Low
-8.07 %
-63.91 %
-167.39 %
(Dec 31 2021)   (Mar 31 2023)







Financial Statements
Invitae's III. Quarter Investments $ 377 Millions NVTA's Balance sheet
Invitae's III. Quarter Income $ -942 Millions Quarterly NVTA's Income Statement
NVTA's Income by Division See NVTA's Income by Division


NVTA Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 1,846 4,775 3,309 700 247
Y / Y Investment Growth -61.34 % 44.33 % 372.85 % 183.7 % 38.81 %
Net Income in Millions -3,106 -379 -602 -242 -129
Y / Y Net Income Growth - - - - -
Annual Return On Investment -168.27 % -7.94 % -18.2 % -34.58 % -52.45 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NVTA's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NVTA's Competitors
Subscribers only: Roi for Invitae's Suppliers
Subscribers only: Return On Investment for NVTA's Customers

Other Ratios
NVTA's Roa NVTA's Inventory Turnover Ratio NVTA's Growth Rates NVTA's Dividend Statistics
NVTA's Profitability Ratios NVTA's Asset Turnover Ratio NVTA's Dividend Growth
NVTA's Roe NVTA's Valuation Ratios NVTA's Financial Strength Ratios NVTA's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-26T07:13:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.